title: [Markers for excessive alcohol use (screening)].
abstract: It is well-known that early diagnosis in addiction leads to a better outcome and prevents psychosocial and medical illness and disability as well as costs. It would be important to have a gold standard for the diagnosis for alcoholism because of the consequences of this diagnosis for both the patient and the physician. In the last 15 years there were world-wide efforts to find biological markers for alcoholism and alcohol abuse. The results, however, were rather poor. With the exception of the relatively new and expensive CDT TEST (Carbohydrate-deficient transferrin) and some changes in established questionnaires (shortenings) we have used the same screening tests for decades. The relationship between the patient and the physician, a detailed medical history and experience of the physician cannot be replaced by tests. The Plinius Major Society recommends in its Guidelines the CAGE questionnaire. In medical settings and in primary care the MALT or AUDIT are more informative. As laboratory markers the Plinius Major Society still recommends: gamma-GT, MCV, GOT/GPT (ASAT/ALAT) and CDT. These tests are only useful if normal values of the particular laboratory are given.
authors.affiliation: Psychiatrische Universitätspoliklinik, Inselspital, Bern. palleman@insel.ch
authors.forename: P I
authors.initials: PI
authors.lastname: Allemann
mesh_terms: D019973:Alcohol-Related Disorders / Q000097:blood / Q000175:diagnosis*; D000437:Alcoholism / Q000097:blood / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D000431:Ethanol / Q000493:pharmacokinetics; D006801:Humans; D008111:Liver Function Tests; D008403:Mass Screening; D010552:Personality Assessment; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D000431:Ethanol